Your browser doesn't support javascript.
loading
Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma.
Zuo, Shan-Ru; Zuo, Xiao-Cong; He, Yang; Fang, Wei-Jin; Wang, Chun-Jiang; Zou, Heng; Chen, Pan; Huang, Ling-Fei; Huang, Li-Hua; Xiang, Hong; Liu, Shi-Kun.
Afiliación
  • Zuo SR; Department of Center Clinical Pharmacology and Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Zuo XC; Department of Center Clinical Pharmacology and Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China.
  • He Y; Department of Center Clinical Pharmacology and Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Fang WJ; Department of Center Clinical Pharmacology and Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Wang CJ; Department of Center Clinical Pharmacology and Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Zou H; Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Chen P; Department of Hepatobiliary Surgery, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Huang LF; Department of Obstetrics and Gynecology, Taizhou Hospital of Zhe Jiang Province, Taizhou, China.
  • Huang LH; Center for Experimental Medicine Research, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Xiang H; Center for Experimental Medicine Research, The Third Xiangya Hospital, Central South University, Changsha, China.
  • Liu SK; Department of Center Clinical Pharmacology and Pharmacy, The Third Xiangya Hospital, Central South University, Changsha, China.
J Cancer ; 9(2): 321-330, 2018.
Article en En | MEDLINE | ID: mdl-29344279

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cancer Año: 2018 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Cancer Año: 2018 Tipo del documento: Article País de afiliación: China